Business
Senseonics Announces CFO Transition
GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing
About this update from Senseonics Holdings, Inc.
[{"type":"text","content":" GERMANTOWN, Md.--(BUSINESS WIRE)--\nSenseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced its Chief Financial Officer, Nick Tressler, is transitioning from his position, effective September 1, 2022. Rick Sullivan, Senseonics' current Vice President of Finance, has been appointed to succeed Mr. Tressler as Chief Financial Officer of Senseonics. Mr. Tressler will remain with Senseonics in a supporting role through the end of the year to ensure an orderly change.\n\n\"Having worked with Rick for over nine years, he has proven to be an integral part of our team and holds an exceptional track record of delivering value and supporting the long-term strategic vision of Senseonics,\" said Tim Goodnow, President and Chief Executive Officer at Senseonics. \"I am confident his leadership ability will drive our operational and financial performance forward.\"\n\nSince October 2020, Mr. Sullivan has served as the Company's Vice President of Finance. Prior to joining Senseonics, he was a Principal at Hike Financial and Chief Financial Officer of RoosterBio. Inc. Additionally, Mr. Sullivan has served as Treasurer and Controller of Senseonics and in progressive finance positions with Senseonics. He received his Masters of Business Administration from the University of Maryland - Robert H. Smith School of Business, his Bachelor of Science in accounting from Salisbury University - Perdue School of Business and is a certified public accountant.\n\n\"On behalf of the Senseonics team, I want to thank Nick for his dedication and expertise over the past three and a half years. He played a key role in supporting our strategic initiatives to create value, building our finance and accounting function, and strengthening the Company's balance sheet. We wish him well in his future endeavors,\" concluded Mr. Goodnow.\n\nAbout Senseonics\n\nSenseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL, and Eversense® E3 include...